Michael L. Meyers
2017
In 2017, Michael L. Meyers earned a total compensation of $933.6K as Chief Medical Officer at Syndax Pharmaceuticals, a 69% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,700 |
|---|---|
| Option Awards | $379,833 |
| Salary | $400,000 |
| Other | $21,047 |
| Total | $933,581 |
Meyers received $400K in salary, accounting for 43% of the total pay in 2017.
Meyers also received $132.7K in non-equity incentive plan, $379.8K in option awards and $21K in other compensation.
Rankings
In 2017, Michael L. Meyers' compensation ranked 9,289th out of 14,666 executives tracked by ExecPay. In other words, Meyers earned more than 36.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,289 out of 14,666 | 37th |
Division Manufacturing | 3,569 out of 5,768 | 38th |
Major group Chemicals And Allied Products | 1,223 out of 2,074 | 41st |
Industry group Drugs | 983 out of 1,730 | 43rd |
Industry Pharmaceutical Preparations | 772 out of 1,329 | 42nd |
Source: SEC filing on April 10, 2018.
Meyers' colleagues
We found two more compensation records of executives who worked with Michael L. Meyers at Syndax Pharmaceuticals in 2017.